Controlled trial of ancrod in ischemic stroke.


Phase N/A Results


Lowering of plasma fibrinogen levels to 100-130 mg/dL with ancrod resulted in a reduction of the apparent blood viscosity. Neurological score improved by 1.1 arbitrary units (AU) in group A and by 2.6 AU in group B. Five patients in group A and two in group B died during the first two weeks.